المؤلفون: Escamilla Gómez, Virginia, García-Gutiérrez, Valentín, López Corral, Lucía, García Cadenas, Irene, Pérez Martínez, Ariadna, Márquez Malaver, Francisco J., Caballero Velázquez, Teresa, Espigado Tocino, Ildefonso, Pérez Simón, José Antonio

المساهمون: Universidad de Sevilla. Departamento de Medicina, CIBERONC

مصطلحات موضوعية: Consensus development project, Available therapy, Clinical-trials, Rapamycini, Brutinib, Resistant, Criteria

العلاقة: Bone Marrow Transplantation, 55 (3), 641-648.; CB16/12/00480; https://www.nature.com/articles/s41409-019-0731-xTest; https://idus.us.es/handle//11441/144619Test

الإتاحة: https://idus.us.es/handle//11441/144619Test

المؤلفون: Bassetti M, Ariyasu M, Binkowitz B, Nagata TD, Echols RM, Matsunaga Y, Toyoizumi K, Doi Y

المصدر: Infection and Drug Resistance, Vol Volume 12, Pp 3607-3623 (2019)

مصطلحات موضوعية: best available therapy, cefiderocol, carbapenem resistance, pathogen-focused study design, rapid diagnostics, streamlined/limited clinical development, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/designing-a-pathogen-focused-study-to-address-the-high-unmet-medical-n-peer-reviewed-article-IDRTest; https://doaj.org/toc/1178-6973Test

الوصول الحر: https://doaj.org/article/0d5a1e13a1f3448aad81157a1afa39a1Test

المؤلفون: Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, Jose Vazquez, Oliver A. Cornely, Joseph Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, Maria Jose Lopez Furst, Eun Jeong Kwak, Francesco Menichetti, Ilana Oren, Elizabeth L. Alexander, David Griffith, Olga Lomovskaya, Jeffery Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye

المصدر: Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 439-455 (2018)

مصطلحات موضوعية: Best available therapy, Carbapenem-resistant Enterobacteriaceae, Meropenem–vaborbactam, Randomized clinical trial, TANGO II, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1007/s40121-018-0214-1Test; https://doaj.org/toc/2193-8229Test; https://doaj.org/toc/2193-6382Test

الوصول الحر: https://doaj.org/article/106733a022be48b9ab7ef1601be3b1a5Test

المؤلفون: Harrison, C.N., Schaap, N., Vannucchi, A.M., Kiladjian, J.J., Jourdan, E., Silver, R.T., Schouten, H.C., Passamonti, F., Zweegman, S., Talpaz, M., Verstovsek, S., Tang, D., Abraham, P., Lord-Bessen, J., Rose, S., Guo, S.E., Liao, W.Q., Mesa, R.A.

المصدر: Harrison , C N , Schaap , N , Vannucchi , A M , Kiladjian , J J , Jourdan , E , Silver , R T , Schouten , H C , Passamonti , F , Zweegman , S , Talpaz , M , Verstovsek , S , Tang , D , Abraham , P , Lord-Bessen , J , Rose , S , Guo , S E , Liao , W Q & Mesa , R A 2021 , ' Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: ....

مصطلحات موضوعية: AVAILABLE THERAPY, DOUBLE-BLIND, COMFORT-II, SURVIVAL, EFFICACY, SAFETY, INHIBITOR, QLQ-C30, UPDATE

الإتاحة: https://doi.org/10.1097/HS9.0000000000000562Test
https://cris.maastrichtuniversity.nl/en/publications/d50a3bf0-99f7-427a-87cc-130f98f2ae9aTest

المؤلفون: Ali, Ridvan, Turgut, Mehmet, Haznedaroglu, Ibrahim C., Yilmaz, Fergun, Aydogdu, Ismet, Pir, Ali, Soyer, Nur

مصطلحات موضوعية: treatment, Myelofibrosis, survival, ruxolitinib, adverse events, International Working Group, World-Health-Organization, Available Therapy, Japanese Patients, Myeloproliferative Neoplasms, Myeloid Neoplasms, Comfort-Ii, Open-Label, Classification, Diagnosis

العلاقة: Turkish Journal Of Medical Sciences; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://search.trdizin.gov.tr/yayin/detay/482288Test; https://doi.org/10.3906/sag-1812-70Test; https://hdl.handle.net/11454/78641Test; ASLANER AK, Müzeyyen/0000-0001-6621-3138; Comert, melda/0000-0002-7798-4349; Ozgur, Gokhan/0000-0003-0357-0503; Haznedaroglu, Ibrahim C./0000-0001-8028-9462; Soyer, Nur/0000-0002-7722-506X; karakus, volkan/0000-0001-9178-2850; yilmaz, fergun/0000-0001-5118-6894; 51; 1033; 1042

الإتاحة: https://doi.org/10.3906/sag-1812-70Test
https://hdl.handle.net/11454/78641Test
https://search.trdizin.gov.tr/yayin/detay/482288Test

المؤلفون: Soyer, Nur, Ali, Ridvan, Turgut, Mehmet, Haznedaroglu, Ibrahim C., Yilmaz, Fergun, Aydogdu, Ismet, Pir, Ali

مصطلحات موضوعية: Myelofibrosis, treatment, survival, ruxolitinib, adverse events, International Working Group, World-Health-Organization, Available Therapy, Japanese Patients, Myeloproliferative Neoplasms, Myeloid Neoplasms, Comfort-Ii, Open-Label, Classification, Diagnosis

العلاقة: Turkish Journal Of Medical Sciences; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.3906/sag-1812-70Test; https://search.trdizin.gov.tr/yayin/detay/482288Test; https://hdl.handle.net/11454/78641Test; 51; 1033; 1042; 482288; WOS:000668244900016; 2-s2.0-85109571239

الإتاحة: https://doi.org/10.3906/sag-1812-70Test
https://hdl.handle.net/11454/78641Test
https://search.trdizin.gov.tr/yayin/detay/482288Test

المؤلفون: Harrison, C.N., Schaap, N., Vannucchi, A.M., Kiladjian, J.J., Jourdan, E., Silver, R.T., Schouten, H.C., Passamonti, F., Zweegman, S., Talpaz, M., Verstovsek, S., Rose, S., Shen, J., Berry, T., Brownstein, C., Mesa, R.A.

المصدر: Harrison , C N , Schaap , N , Vannucchi , A M , Kiladjian , J J , Jourdan , E , Silver , R T , Schouten , H C , Passamonti , F , Zweegman , S , Talpaz , M , Verstovsek , S , Rose , S , Shen , J , Berry , T , Brownstein , C & Mesa , R A 2020 , ' Fedratinib in patients with myelofibrosis previously treated with ruxolitinib : An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure ' , American Journal ....

مصطلحات موضوعية: available therapy, double-blind, efficacy, encephalopathy, inhibitor fedratinib, open-label, outcomes, phase-3, safety, sar302503

الإتاحة: https://doi.org/10.1002/ajh.25777Test
https://cris.maastrichtuniversity.nl/en/publications/ab793601-9c16-42c0-9fb3-e453a23756e7Test

المؤلفون: Bassetti M., Ariyasu M., Binkowitz B., Nagata T. D., Echols R. M., Matsunaga Y., Toyoizumi K., Doi Y.

المساهمون: Bassetti, M., Ariyasu, M., Binkowitz, B., Nagata, T. D., Echols, R. M., Matsunaga, Y., Toyoizumi, K., Doi, Y.

مصطلحات موضوعية: Best available therapy, Carbapenem resistance, Cefiderocol, Pathogen-focused study design, Rapid diagnostic, Streamlined/limited clinical development

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000503941600001; volume:12; firstpage:3607; lastpage:3623; numberofpages:17; journal:INFECTION AND DRUG RESISTANCE; http://hdl.handle.net/11390/1171259Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85075417194; https://www.dovepress.com/getfile.php?fileID=54153Test

الإتاحة: https://doi.org/10.2147/IDR.S225553Test
http://hdl.handle.net/11390/1171259Test
https://www.dovepress.com/getfile.php?fileID=54153Test

المؤلفون: Rahul Kumar (136775), Öznur Aktay-Cetin (11994833), Vaughn Craddock (14419695), Daniel Morales-Cano (668199), Djuro Kosanovic (8930759), Angel Cogolludo (668204), Francisco Perez-Vizcaino (4794699), Sergey Avdeev (8930753), Ashok Kumar (43100), Anil Kumar Ram (14419698), Stuti Agarwal (10727448), Ananya Chakraborty (5440382), Rajkumar Savai (192633), Vinicio de Jesus Perez (10231637), Brian B. Graham (12413449), Ghazwan Butrous (14419701), Navneet K. Dhillon (14419704)

مصطلحات موضوعية: Medicine, Microbiology, Biotechnology, Evolutionary Biology, Ecology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, past two years, molecular signals involved, may consequently lead, investigators accumulated evidence, emphasize recent updates, coronavirus disease 2019, although targeting primarily, currently available therapies, immune responses associated, comorbidities , available therapy, immune system, immune cells, %22">xlink ">, well established, virus triggers, viral infection, term effects, term consequences

العلاقة: https://figshare.com/articles/figure/Comorbidities_that_may_synergize_with_COVID-19_to_predispose_risks_to_PH_/21891186Test

الإتاحة: https://doi.org/10.1371/journal.ppat.1011063.g002Test

المؤلفون: Rahul Kumar (136775), Öznur Aktay-Cetin (11994833), Vaughn Craddock (14419695), Daniel Morales-Cano (668199), Djuro Kosanovic (8930759), Angel Cogolludo (668204), Francisco Perez-Vizcaino (4794699), Sergey Avdeev (8930753), Ashok Kumar (43100), Anil Kumar Ram (14419698), Stuti Agarwal (10727448), Ananya Chakraborty (5440382), Rajkumar Savai (192633), Vinicio de Jesus Perez (10231637), Brian B. Graham (12413449), Ghazwan Butrous (14419701), Navneet K. Dhillon (14419704)

مصطلحات موضوعية: Medicine, Microbiology, Biotechnology, Evolutionary Biology, Ecology, Immunology, Cancer, Mental Health, Infectious Diseases, Virology, Biological Sciences not elsewhere classified, past two years, molecular signals involved, may consequently lead, investigators accumulated evidence, emphasize recent updates, coronavirus disease 2019, although targeting primarily, currently available therapies, immune responses associated, comorbidities , available therapy, immune system, immune cells, %22">xlink ">, well established, virus triggers, viral infection, term effects, term consequences

العلاقة: https://figshare.com/articles/figure/Acute_response_to_SARS-CoV-2_infection_in_alveolar_and_vascular_compartments_/21891183Test

الإتاحة: https://doi.org/10.1371/journal.ppat.1011063.g001Test